What’s Happening? SEERS Technology IR Scheduled!
SEERS Technology will hold a Non-Deal Roadshow (NDR) for domestic institutional investors on September 22, 2025, at 9:00 AM. The company plans to actively communicate its corporate value and future growth potential through presentations on major business updates and a Q&A session.
Why Is It Important? Growth Momentum and Increased Investor Interest
SEERS Technology is showing remarkable growth in the medical device and IoMT platform-based diagnostic support and patient monitoring solutions market. In the first half of 2025, revenue increased by 48.7% year-on-year to KRW 12.022 billion, with the thynC™ solution achieving an astounding 135% growth. This IR presents a crucial opportunity to further solidify this growth momentum and attract potential investors.
Key IR Topics and Potential Impact?
The IR is expected to cover key topics such as the continued growth drivers of thynC™, mobiCARE™ business expansion plans, AI technology integration, strategies to diversify customer concentration, and R&D investment strategies. Positive announcements could lead to stock price appreciation, while unmet expectations or deteriorating market conditions could have a negative impact.
- Positive Scenario: Continued thynC™ growth, securing new partnerships, and successful customer diversification could improve investor sentiment and drive stock prices higher.
- Negative Scenario: Slowing growth, continued customer concentration, and intensified market competition could dampen investor sentiment and lead to a decline in stock price.
What Should Investors Do? Monitor IR Content and Market Conditions
Investors should carefully review the information presented at the IR and thoroughly analyze the company’s growth strategies and risk management plans. It’s also crucial to continuously monitor macroeconomic factors and market conditions to inform investment decisions.